{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:43:22Z","timestamp":1788752602876,"version":"build-2803163510"},"reference-count":45,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,5,15]]},"DOI":"10.2169\/internalmedicine.4420-24","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T22:11:53Z","timestamp":1729203113000},"page":"1451-1458","source":"Crossref","is-referenced-by-count":4,"title":["Association between Clinical Characteristics and Sarcopenia or Sarcopenic Obesity in Crohn's Disease"],"prefix":"10.2169","volume":"64","author":[{"given":"Takumi","family":"Naruse","sequence":"first","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Kawata","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Feuerstein JD, Cheifetz AS. Crohn disease: epidemiology, diagnosis, and management. Mayo Clin Proc 92: 1088-1103, 2017.","DOI":"10.1016\/j.mayocp.2017.04.010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dieleman LA, Heizer WD. Nutritional issues in inflammatory bowel disease. Gastroenterol Clin North Am 27: 435-451, 1998.","DOI":"10.1016\/S0889-8553(05)70012-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hebuterne X, Filippi J, Schneider SM. Nutrition in adult patients with inflammatory bowel disease. Curr Drug Targets 15: 1030-1038, 2014.","DOI":"10.2174\/1389450115666140930150047"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Dhaliwal A, Quinlan JI, Overthrow K, et al. Sarcopenia in inflammatory bowel disease: a narrative overview. Nutrients 13: 656, 2021.","DOI":"10.3390\/nu13020656"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 139: 1147-1155, 2010.","DOI":"10.1053\/j.gastro.2010.06.070"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 68: 1115-1126, 2019.","DOI":"10.1136\/gutjnl-2018-318081"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bouhnik Y, Carbonnel F, Laharie D, et al. Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut 67: 53-60, 2018.","DOI":"10.1136\/gutjnl-2016-312581"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. W\u0119drychowicz A, Zaj\u0105c A, Tomasik P. Advances in nutritional therapy in inflammatory bowel diseases: review. World J Gastroenterol 22: 1045-1066, 2016.","DOI":"10.3748\/wjg.v22.i3.1045"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Aksan A, Farrag K, Blumenstein I, et al. Chronic intestinal failure and short bowel syndrome in Crohn's disease. World J Gastroenterol 27: 3440-3465, 2021.","DOI":"10.3748\/wjg.v27.i24.3440"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 393: 2636-2646, 2019.","DOI":"10.1016\/S0140-6736(19)31138-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yasueda A, Sekido Y, Takeda T, et al. Sarcopenia hinders the decline in disease activity after surgery for people with Crohn's disease: preliminary results. Nutrition 94: 111526, 2022.","DOI":"10.1016\/j.nut.2021.111526"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bamba S, Sasaki M, Takaoka A, et al. Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease. PLoS One 12: e0180036, 2017.","DOI":"10.1371\/journal.pone.0180036"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhang T, Cao L, Cao T, et al. Prevalence of sarcopenia and its impact on postoperative outcome in patients with Crohn's disease undergoing bowel resection. JPEN J Parenter Enteral Nutr 41: 592-600, 2017.","DOI":"10.1177\/0148607115612054"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gonz\u00e1lez-Muniesa P, M\u00e1rtinez-Gonz\u00e1lez MA, Hu FB, et al. Obesity. Nat Rev Dis Primers 3: 17034, 2017.","DOI":"10.1038\/nrdp.2017.34"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 35: 200-221, 2017.","DOI":"10.1016\/j.arr.2016.09.008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Park KS, Lee DH, Lee J, et al. Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. J Diabetes Complications 30: 343-349, 2016.","DOI":"10.1016\/j.jdiacomp.2015.10.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Holmes CJ, Racette SB. The utility of body composition assessment in nutrition and clinical practice: an overview of current methodology. Nutrients 13: 2493, 2021.","DOI":"10.3390\/nu13082493"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mizusawa T, Sato H, Kamimura K, et al. Change in body composition in patients with achalasia before and after peroral endoscopic myotomy. J Gastroenterol Hepatol 35: 601-608, 2020.","DOI":"10.1111\/jgh.14847"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ara\u00fajo AM, Machado HS, Falc\u00e3o AC, et al. Bioelectrical impedance analysis of body composition for the anesthetic induction dose of propofol in older patients. BMC Anesthesiol 19: 180, 2019.","DOI":"10.1186\/s12871-019-0856-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sullivan PA, Still CD, Jamieson ST, et al. Evaluation of multi-frequency bioelectrical impedance analysis for the assessment of body composition in individuals with obesity. Obes Sci Pract 5: 141-147, 2019.","DOI":"10.1002\/osp4.321"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 56: 489-526, 2021.","DOI":"10.1007\/s00535-021-01784-1"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55: 749-753, 2006.","DOI":"10.1136\/gut.2005.082909"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70: 439-444, 1976.","DOI":"10.1016\/S0016-5085(76)80163-1"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 77: 843-846, 1979.","DOI":"10.1016\/0016-5085(79)90384-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 23: 1226-1243, 2004.","DOI":"10.1016\/j.clnu.2004.06.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gonzalez MC, Heymsfield SB. Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? J Cachexia Sarcopenia Muscle 8: 187-189, 2017.","DOI":"10.1002\/jcsm.12159"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Makizako H, Nakai Y, Tomioka K, et al. Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults: a systematic review and meta-analysis. Phys Ther Res 22: 53-57, 2019.","DOI":"10.1298\/ptr.R0005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Moon JJ, Park SG, Ryu SM, et al. New skeletal muscle mass index in diagnosis of sarcopenia. J Bone Metab 25: 15-21, 2018.","DOI":"10.11005\/jbm.2018.25.1.15"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sergi G, De Rui M, Stubbs B, et al. Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clin Exp Res 29: 591-597, 2017.","DOI":"10.1007\/s40520-016-0622-6"},{"key":"30","unstructured":"30. Ministry of Health, Labour and Welfare. Obesity and health. e-Health Net [Internet]. 2019. Available from: https:\/\/www.e-healthnet.mhlw.go.jp\/information\/food\/e-02-001.html"},{"key":"31","unstructured":"31. Kobayashi S, Yamagata Z, Kinoshita T, Kobayashi K, Asaka A. The study of the standard body fat ratio. Off J Jpn Soc Hum Dry Dock 14: 54-56, 1999 (in Japanese)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"33","unstructured":"33. World Health Organization. Obesity and overweight [Internet]. [cited 2024 Mar 1]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lee JY, Kim KW, Ko Y, et al. Serial changes in body composition and the association with disease activity during treatment in patients with Crohn's disease. Diagnostics (Basel) 12: 2804, 2022.","DOI":"10.3390\/diagnostics12112804"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Rocha R, Santana GO, Almeida N, et al. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase. Br J Nutr 101: 676-679, 2009.","DOI":"10.1017\/S0007114508032224"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Massironi S, Vigan\u00f2 C, Palermo A, et al. Inflammation and malnutrition in inflammatory bowel disease. Lancet Gastroenterol Hepatol 8: 579-590, 2023.","DOI":"10.1016\/S2468-1253(23)00011-0"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Bullock AF, Greenley SL, McKenzie GAG, et al. Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis. Eur J Clin Nutr 74: 1519-1535, 2020.","DOI":"10.1038\/s41430-020-0629-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Karchynskaya V, Kopcakova J, Klein D, et al. Is BMI a valid indicator of overweight and obesity for adolescents? Int J Environ Res Public Health 17: 4815, 2020.","DOI":"10.3390\/ijerph17134815"},{"key":"39","unstructured":"39. Casanova MJ, Chaparro M, Molina B, et al. Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease. J Crohns Colitis 11: 1430-1439, 2017."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Bryant RV, Trott MJ, Bartholomeusz FD, et al. Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther 38: 213-225, 2013.","DOI":"10.1111\/apt.12372"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Stenholm S, Harris T, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 11: 693-700, 2008.","DOI":"10.1097\/MCO.0b013e328312c37d"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Bischoff SC, Barazzoni R, Busetto L, et al. European guideline on obesity care in patients with gastrointestinal and liver diseases - joint ESPEN\/UEG guideline. Clin Nutr 41: 2364-2405, 2022.","DOI":"10.1016\/j.clnu.2022.07.003"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. van Langenberg DR, Della Gatta P, Hill B, Zacharewicz E, Gibson PR, Russell AP. Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease. J Crohns Colitis 8: 626-634, 2014.","DOI":"10.1016\/j.crohns.2013.11.024"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Pedersen BK, Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 107: 1006-1014, 2009.","DOI":"10.1152\/japplphysiol.00734.2009"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48: 16-31, 2019.","DOI":"10.1093\/ageing\/afy169"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/10\/64_4420-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:26:33Z","timestamp":1747452393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/10\/64_4420-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4420-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"4420-24"}}